RT Journal Article
SR Electronic
T1 679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A770
OP A770
DO 10.1136/jitc-2023-SITC2023.0679
VO 11
IS Suppl 1
A1 Ho, Alan L
A1 Pearson, Alexander T
A1 Fu, Siqing
A1 Posner, Marshall R
A1 Adkins, Douglas
A1 Nabell, Lisle
A1 Niu, Jiaxin
A1 Richardson, Debra L
A1 Leidner, Rom S
A1 Chung, Ki
A1 Laux, Douglas
A1 Nieva, Jorge
A1 Wong, Stuart
A1 Rojas, Katerin
A1 Rosenberg, Ari J
A1 Phan, Minh
A1 Kaufmann, Trisha
A1 Plescia, Christopher
A1 Qing, Xiaoping
A1 Iacobucci, Corinne
A1 Tchakov, Ilian
A1 Katchar, Kia
A1 Orlinger, Klaus
A1 Schlienger, Katia
A1 Pfister, David G
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A770.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.